1. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis
   Bin Liang et al, 2017, Scientific Reports CrossRef
2. Targeting the Mammalian Target of Rapamycin in Lung Cancer
   Glenn W. Vicary et al, 2016, The American Journal of the Medical Sciences CrossRef
3. AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma
   MIN HU et al, 2014, Oncology Reports CrossRef
4. mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production
   Feidi Chen et al, 2016, The Journal of Immunology CrossRef
5. miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway
   Li Wang et al, 2014, Medical Oncology CrossRef
6. Targeting cancer cell mitochondria as a therapeutic approach: recent updates
   Qingbin Cui et al, 2017, Future Medicinal Chemistry CrossRef
7. Mechanism of Regulation of Big-Conductance Ca2+-Activated K+ Channels by mTOR Complex 2 in Podocytes
   Yinhang Wang et al, 2019, Frontiers in Physiology CrossRef
8. Potential impact of mTOR inhibitors on cervical squamous cell carcinoma: A systematic review
   Daniele Xavier Assad et al, 2016, Oncology Letters CrossRef
9. Anticancer effects of combinational treatment with BRAFV600E siRNA and PI3K pathway inhibitors in melanoma cell lines harboring BRAFV600E
   Hongyan He et al, 2018, Oncology Letters CrossRef
10. Development of clinically effective formulations for anticancer applications: why it is so difficult?
    David Needham, 2020, Biomaterials for Cancer Therapeutics CrossRef
11. Glutamine switches vascular smooth muscle cells to synthetic phenotype through inhibiting miR-143 expression and upregulating THY1 expression
    Chun-Yan Zhang et al, 2021, Life Sciences CrossRef
12. Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational
    Kamran Mansouri et al, 2020, Biomedicine & Pharmacotherapy CrossRef
13. Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
    Haiying Cheng et al, 2014, Lung Cancer Management CrossRef
14. Metabolite identification of AZD8055 in Sprague-Dawley rats after a single oral administration using ultra-performance liquid chromatography and mass spectrometry
    Md Mamunur Rashid et al, 2017, Journal of Pharmaceutical and Biomedical Analysis CrossRef
15. Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo
    Dong-Qing Xu et al, 2018, Experimental Cell Research CrossRef
16. 2-Deoxyglucose Induces Cell Cycle Arrest and Apoptosisin Colorectal Cancer Cells Independent of Its Glycolysis Inhibition
    Pratik Muley et al, 2015, Nutrition and Cancer CrossRef
17. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer
    Shuai Huang et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
18. Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance
    Junying Zhou et al, 2022, Frontiers in Oncology CrossRef
19. Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes
    Talha Abdul Halim et al, 2013, Cancer Cell International CrossRef
20. Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma
    Gireesh B. Reddy et al, 2020, Molecular Cancer Therapeutics CrossRef
21. Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages
    Weimin Hu et al, 2023, Heliyon CrossRef
22. Proteomic responses of BEAS-2B cells to nontoxic and toxic chromium: Protein indicators of cytotoxicity conversion
    Maribel Bruno et al, 2016, Toxicology Letters CrossRef